[Subciliary approach in orbital surgery].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Gary-Bobo.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The authors suggest a one-stage treatment for craniofaciostenosis, using two surgical teams, to try to correct both the functional problems and morphological disorders.
A method for treating combined fractures of the mandible and subcondylar region is described. The mandibular fracture is treated by bicortical screws, with or without plates according to the type of fracture. The subcondylar fracture is treated by functional reduction using the technique described by Delaire. An analysis of the results obtained in four cases out of 23 is reported. These were chosen or followed by the same surgeon, and radiological examination conducted using the same incidences.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
It would appear that pre-operative radiotherapy early in the treatment of oesophageal cancer has avoided in many cases (especially those in an advanced stage), the appearance of local recurrences, which cause death very rapidly during the first year in those patients having surgical treatment only. This treatment, however, which is only localized to the mediastinum, has not prevented the appearance of metastases at a later date. It is obvious, therefore, that though we have improved local prognosis by localized and regional treatment, and the association of radiotherapy and surgery, we have not been able to act on the residual cancerous disease, and something else is needed. This "something else" must be chemotherapy, but at the present time we do not know which product, at which dose, and at which moment, this chemotherapy should be applied to be most effective.
Explore the source record for details and available documents.
Explore the source record for details and available documents.